Fertility
CCL is constantly introducing new technologies for diagnostics to the UK market, including those that will improve personalised care options in fertility.
FSHR POLYMORPHISM TEST
The first and only UK test for pharmacogenomics in fertility. The test looks at DNA involved in recognising and responding to FSHR. It will indicate the type of receptors in the patient’s ovaries. The result will help clinicians to decide on the best treatment pathway and help to improve the chance of IVF success.
To find out more about this test visit pmorph.com or read the patient and/or HCP leaflet.
